The Shanghai Stock Exchange’s new Technology Innovation Board will allow still-unprofitable hi-tech companies – including biopharmas – to IPO on the exchange, though each IPOing company must have …
( read original story …)
The Shanghai News
The Shanghai Stock Exchange’s new Technology Innovation Board will allow still-unprofitable hi-tech companies – including biopharmas – to IPO on the exchange, though each IPOing company must have …
( read original story …)